Retatrutide
Retatrutide is a high-purity research compound supplied as a lyophilized powder in a sealed, sterile glass vial. Retatrutide is a novel triple-agonist peptide activating GLP-1, GIP, and glucagon receptors simultaneously, studied for synergistic effects on metabolic pathways, energy homeostasis, and body composition in preclinical models. Manufactured using solid-phase peptide synthesis (SPPS) and purified via preparative HPLC to ≥99% purity, with identity confirmed by LC-MS. Reconstitute with sterile bacteriostatic water before use. Store lyophilized vials at -20°C for long-term storage or 2-8°C for short-term. For laboratory and research use only. Not for human or veterinary use.
Product Details
Retatrutide is synthesized using advanced solid-phase peptide synthesis (SPPS) technology and purified to ≥99% via preparative HPLC. Each vial contains lyophilized peptide verified by electrospray ionization mass spectrometry (ESI-MS) for exact molecular mass confirmation. The lyophilization process is performed under inert nitrogen atmosphere to prevent oxidation and ensure maximum shelf stability. Reconstitute with bacteriostatic water for optimal peptide preservation. Store reconstituted solutions at 2-8°C and use within 30 days.
Research Focus & Mechanism Overview
Retatrutide is a novel triple-agonist peptide activating GLP-1, GIP, and glucagon receptors simultaneously, studied for synergistic effects on metabolic pathways, energy homeostasis, and body composition in preclinical models. Researchers should note the compound's stability profile under various buffer conditions when designing experimental protocols. Recommended for use in comparative pharmacological profiling, receptor binding assays, dose-response characterization, and mechanistic pathway studies.
Quality & Purity Standards
Every batch is tested in-house and verified by independent third-party laboratories. Purity ≥99% by HPLC. Identity confirmed via LC-MS. Endotoxin levels <0.1 EU/mg. Heavy metals below ICH Q3D limits. Peptide content ≥80% by weight (net peptide). Certificate of Analysis (COA) available for download on this page.
Compliance Notice
This product is intended solely for in-vitro research and laboratory use. It is not a drug, food, supplement, or cosmetic. Not approved for human or veterinary use. Purchasers assume full responsibility for compliance with applicable local, state, and federal regulations. By purchasing, you confirm that you are a qualified researcher or institution and that this product will not be used for any unauthorized purpose.
Also Considered.
FREQUENTLY ASKED
QUESTIONS
How should I reconstitute Retatrutide?
Slowly inject bacteriostatic water along the inside wall of the vial to avoid foaming. Do not shake — gently swirl until the powder is fully dissolved. Use sterile technique throughout. Store reconstituted solution refrigerated at 2-8°C and use within 30 days.
What purity is guaranteed for Retatrutide?
Every batch is tested in-house via HPLC and independently verified by third-party LC-MS analysis. We guarantee a minimum purity of ≥99%. Certificates of Analysis (COA) are available for download on each product page.
How should I store Retatrutide?
Store lyophilized (unreconstituted) vials at -20°C for long-term storage or 2-8°C for short-term. Protect from light and moisture. Reconstituted peptide should be kept refrigerated at 2-8°C and used within 30 days. Avoid repeated freeze-thaw cycles.
What is the difference between the 10mg, 20mg, 30mg, 50mg vials?
Both vials contain the same Retatrutide at identical purity. The only difference is the amount of lyophilized peptide per vial. Choose based on your research protocol's dosing requirements.
Is this product approved for human use?
No. All Sparta Labs products are strictly intended for in-vitro laboratory research only. They are not drugs, supplements, or food products. Not approved by the FDA or any regulatory body for human or veterinary use.